Northeastern University Researchers Lead in Computing and Pharmaceutical Innovations
Two distinguished faculty members from Northeastern University have achieved recognition as fellows of the National Academy of Inventors. This honor signifies one of the highest accolades in academic innovation. The recipients are Gregory Abowd, dean of the College of Engineering, and Mansoor Amiji, a prominent professor in the Bouvé College of Health Sciences.
Northeastern University’s Contributions to Computing and Pharmaceutical Innovations
The National Academy of Inventors, established in 2010, includes over 300 institutions and features more than 4,600 individual members. Gregory Abowd and Mansoor Amiji’s selection underscores their significant contributions to their respective fields.
Gregory Abowd’s Innovations in Education Technology
Gregory Abowd is recognized for his pioneering efforts in human-computer interaction. In the mid-1990s, he developed one of the earliest classroom prototypes, known as Classroom 2000. This initiative showcased the integration of computing technologies in education.
- Focused on enhancing accessibility and communication through technology.
- Collaborated with the autism community to create diagnostic and management tools.
- Developed a mobile app for blind users to type braille on their devices.
- Contributed to the AWARE home project, which utilized signaling technologies for data collection.
Abowd holds 21 U.S. patents and has founded five technology companies, including one acquired by Belkin. He expressed gratitude, attributing his success to the collaborative efforts with innovative students and industry partners.
Mansoor Amiji’s Breakthroughs in Pharmaceutical Technology
Mansoor Amiji has dedicated over three decades to advancing vaccine delivery systems and pharmaceutical technologies. His research aims to address cancer, neurodegenerative diseases, and gastrointestinal disorders. Amiji has filed over 25 patents through his lab at Northeastern.
- Conducting clinical trials for an oil-droplet drug delivery system targeting cancer.
- Developing treatments for brain cancer and conditions like Parkinson’s and Alzheimer’s.
- Collaborating with over 25 pharmaceutical companies to translate discoveries into clinical applications.
Amiji holds more than 30 patents and has co-founded multiple biotechnology companies. He credited his honor to the support and teamwork of his students and colleagues, emphasizing the collaborative nature of scientific innovation.
Conclusion
The achievements of Gregory Abowd and Mansoor Amiji not only highlight their individual contributions but also reflect Northeastern University’s commitment to advancing computing and pharmaceutical innovations. Their work continues to impact various sectors, paving the way for future breakthroughs in technology and healthcare.
